These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 32011461)
1. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: A case report. Mărginean MO; Molnar E; Chinceşan MI Medicine (Baltimore); 2020 Jan; 99(3):e18759. PubMed ID: 32011461 [TBL] [Abstract][Full Text] [Related]
2. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications. Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient. Matsuo Y; Iwanami K; Hiraoka E; Oda R Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119 [TBL] [Abstract][Full Text] [Related]
5. Ruxolitinib in conjunction with the HLH-94 protocol for Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in the intensive care unit: A case report. Huang Z; Xie J Medicine (Baltimore); 2021 Mar; 100(11):e25188. PubMed ID: 33726009 [TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood]. Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937 [TBL] [Abstract][Full Text] [Related]
7. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol. Lee JS; Kang JH; Lee GK; Park HJ J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988 [TBL] [Abstract][Full Text] [Related]
9. Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus. Ueda T; Itabashi T; Yamanishi S; Tanabe Y; Migita M; Itoh Y J Nippon Med Sch; 2020 Jul; 87(3):166-170. PubMed ID: 32238729 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report. Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347 [TBL] [Abstract][Full Text] [Related]
12. Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia. Min KW; Jung HY; Han HS; Hwang TS; Kim SY; Kim WS; Lim SD; Kim WY APMIS; 2015 Jan; 123(1):81-6. PubMed ID: 25243347 [TBL] [Abstract][Full Text] [Related]
13. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955 [TBL] [Abstract][Full Text] [Related]
15. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Song Y; Wang Y; Wang Z Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044 [TBL] [Abstract][Full Text] [Related]
16. [Hemophagocytic syndrome associated with Epstein-Barr virus. Presentation of a case and treatment in the Resuscitation Unit]. Figueiredo González O; Iglesias Fernández M; Río Gómez A; Ulibarrena Redondo C; Casas García ML Rev Esp Anestesiol Reanim; 2014 Dec; 61(10):571-4. PubMed ID: 24468010 [TBL] [Abstract][Full Text] [Related]
17. Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report. Takahashi M; Makino S; Iizuka H; Noguchi M; Yoshida K BMC Pregnancy Childbirth; 2021 Oct; 21(1):681. PubMed ID: 34620104 [TBL] [Abstract][Full Text] [Related]
18. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center. Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882 [No Abstract] [Full Text] [Related]
19. Dermatopathic lymphadenitis with generalized erythroderma in a patient with epstein-barr virus-associated hemophagocytic lymphohistiocytosis. Lee WJ; Lee DW; Kim CH; Won CH; Chang SE; Lee MW; Choi JH; Moon KC Am J Dermatopathol; 2010 Jun; 32(4):357-61. PubMed ID: 20010284 [TBL] [Abstract][Full Text] [Related]
20. Unrelated bone marrow transplantation induced long-term remission in a patient with life-threatening Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Kunitomi A; Kimura H; Ito Y; Naitoh K; Noda N; Iida H; Sao H J Clin Exp Hematop; 2011; 51(1):57-61. PubMed ID: 21628862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]